Adjuvant chemotherapy in early-stage endometrioid endometrial cancer with >50% myometrial invasion and negative lymph nodes.
Francesco MultinuSimone GarzonAmy L WeaverMichaela E McGreeEnrico SartoriFabio LandoniPaolo ZolaGiorgia DinoiGiovanni AlettiMatthew S BlockAngiolo GadducciAndrea MarianiPublished in: International journal of gynecological cancer : official journal of the International Gynecological Cancer Society (2021)
Although we observed that adjuvant chemotherapy was associated with improved oncologic outcomes in early-stage high-risk endometrioid endometrial cancer, the associations did not meet conventional levels of statistical significance. Further research is warranted in this relatively uncommon subgroup of patients.
Keyphrases
- endometrial cancer
- early stage
- lymph node
- end stage renal disease
- ejection fraction
- newly diagnosed
- chronic kidney disease
- prognostic factors
- peritoneal dialysis
- squamous cell carcinoma
- rectal cancer
- adipose tissue
- patient reported outcomes
- cell migration
- metabolic syndrome
- neoadjuvant chemotherapy
- radical prostatectomy
- study protocol